Imciromab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5597
Add to Compare
$710.00 - $6,900.00
Delivery Time : 4 weeks

Imciromab Biosimilar - Research Grade

Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
myosin, cardiac [Homo sapiens]
Concentration
5mg/ml
Isotype
Fab - G2a - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
Cardiac myosin is a structural contractile protein of the heart muscle and, when released by myocyte injury, a marker exploited in cardiovascular and myocardial damage research. Our research-grade anti-cardiac myosin Fab is an unconjugated, non-therapeutic analog of imciromab, intended strictly for research use only (RUO). Prepared to rigorous in vivo standards, this ultra-pure, low-endotoxin reagent is supplied in scalable milligram (mg) to gram (g) quantities to serve high-throughput, heavy-usage laboratories. It is well suited to antigen-binding and detection assays, in vitro screening, control reagent applications, and in vivo cardiac injury models.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review
You're reviewing:Imciromab Biosimilar - Research Grade
Your Rating
Back to Top